+

WO2008147169A8 - Microemolsion conteniendo pirfenidona - Google Patents

Microemolsion conteniendo pirfenidona Download PDF

Info

Publication number
WO2008147169A8
WO2008147169A8 PCT/MX2008/000068 MX2008000068W WO2008147169A8 WO 2008147169 A8 WO2008147169 A8 WO 2008147169A8 MX 2008000068 W MX2008000068 W MX 2008000068W WO 2008147169 A8 WO2008147169 A8 WO 2008147169A8
Authority
WO
WIPO (PCT)
Prior art keywords
microemulsion containing
containing pirfenidone
pirfenidone
microemulsion
capsules
Prior art date
Application number
PCT/MX2008/000068
Other languages
English (en)
French (fr)
Other versions
WO2008147169A3 (es
WO2008147169A2 (es
Inventor
José Agustín Rogelio MAGAÑA CASTRO
Juan Socorro Armendariz Borunda
Laura VÁZQUEZ CERVANTES
Original Assignee
Cell Therapy Technology, S.A. De C.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cell Therapy Technology, S.A. De C.V. filed Critical Cell Therapy Technology, S.A. De C.V.
Publication of WO2008147169A2 publication Critical patent/WO2008147169A2/es
Publication of WO2008147169A3 publication Critical patent/WO2008147169A3/es
Publication of WO2008147169A8 publication Critical patent/WO2008147169A8/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención describe una composición microemulsionable de Pirfenidona, que ofrece ventajas sobre otras formas farmacéuticas de administración oral conocidas en el estado de la técnica, como son tabletas, cápsulas, suspensiones y soluciones.
PCT/MX2008/000068 2007-05-29 2008-05-29 Microemolsion conteniendo pirfenidona WO2008147169A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MXMX/A/2007/006348 2007-05-29
MX2007006438 2007-05-29

Publications (3)

Publication Number Publication Date
WO2008147169A2 WO2008147169A2 (es) 2008-12-04
WO2008147169A3 WO2008147169A3 (es) 2009-01-22
WO2008147169A8 true WO2008147169A8 (es) 2009-07-30

Family

ID=40075678

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/MX2008/000068 WO2008147169A2 (es) 2007-05-29 2008-05-29 Microemolsion conteniendo pirfenidona

Country Status (1)

Country Link
WO (1) WO2008147169A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2296653B1 (en) 2008-06-03 2016-01-27 Intermune, Inc. Compounds and methods for treating inflammatory and fibrotic disorders
CN102846555B (zh) * 2012-04-09 2014-06-25 珠海亿邦制药股份有限公司 一种以吡非尼酮为活性成分的固体制剂及其应用
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
MX382781B (es) 2014-04-02 2025-03-13 Intermune Inc Piridinonas anti-fibroticas.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002526447A (ja) * 1998-09-18 2002-08-20 メファ・アクチェンゲゼルシャフト アルキルフェニルピリドンの局所製剤
CH696420A5 (de) * 2002-09-13 2007-06-15 Mepha Ag Neue stabile Zubereitungen von Alkyl-, Phenyl-Pyridonen für topische Anwendung.
JP4542743B2 (ja) * 2002-12-26 2010-09-15 Ｋｄｌ株式会社 ピリドン誘導体の溶液状医薬組成物
NZ591443A (en) * 2005-09-22 2013-04-26 Intermune Inc Granule formation of pirfenidone and pharmaceutically acceptable excipients

Also Published As

Publication number Publication date
WO2008147169A3 (es) 2009-01-22
WO2008147169A2 (es) 2008-12-04

Similar Documents

Publication Publication Date Title
WO2008037716A3 (en) Pharmaceutical compositions comprising nilotinib or its salt
WO2007052289A3 (en) Novel dispersible tablet composition
WO2010066749A3 (en) Ulipristal acetate tablets
SI1830855T1 (sl) Trdne oralno aplikabilne farmacevtske dajalne oblike z modificiranim sproščanjem ki vsebujejo rivaroksaban
NO20085302L (no) Farmasoytisk preparat omfattende Amlodipin og Losartan
AP2384A (en) 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them.
JP2009537554A5 (es)
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2003026610A3 (en) Process for the preparation of fast dissolving dosage form
WO2008006534A3 (en) Multiple unit tablets
WO2010049449A3 (en) Novel salts of sunitinib
WO2006134021A3 (en) Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof
HUP0401522A2 (en) New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation
WO2010012459A3 (en) A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms
WO2007083190A3 (en) Water insoluble helichrysum extract, process for preparing the same and uses thereof
WO2008147169A3 (es) Microemolsion conteniendo pirfenidona
WO2006122777A3 (de) Verwendung von 2,5-disubstituierten thiazol-4-on-derivaten in arzneimitteln
WO2007007182A3 (en) Solid and liquid dosage forms of an antiepileptic agent
WO2008059298A3 (en) Pharmaceutical composition containing clopidogrel hydrogenesulphate of polymorph 1 form
WO2009049961A3 (en) New no-donor aspirin derivatives
PL1589014T3 (pl) Sposób syntezy pochodnych 1,3-dihydro-2H-3-benzazepin-2-onu i jego zastosowanie do wytwarzania iwabradyny i jej dopuszczalnych farmaceutycznie soli
WO2009056617A3 (en) 4,4-disubstituted piperdines as renin inhibitors
WO2009110010A3 (en) Oral dosage form comprising amlodipine and olmesartan
WO2009074674A3 (en) Trisubstituted piperidines as renin inhibitors
PT1819320E (pt) Composição farmacêutica dispersável oralmente e processo para a sua preparação

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08766683

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct app. not ent. europ. phase

Ref document number: 08766683

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载